Process Considerations for Cryogenic and Regenerative Medicine Commercialization

McKesson, Fisher BioServices, GE Healthcare and Cryoport are proud to announce our first annual workshop. Our FREE two-day workshop will provide a forum for industry experts to present and discuss current technological advancements in cryogenic management, regulatory requirements and best practices for processes in the support of regenerative medicine commercialization.

The event is aimed at biotechnology and pharmaceutical professionals who want to learn more about the critical considerations for the development and commercialization of these vital therapies.

To download the complete White Paper click here